Xenon Pharmaceuticals (XENE) - Earnings per share increase in current year

Official company branding of Xenon Pharmaceuticals (XENE)

Xenon Pharmaceuticals revenues are based on the future commercialization of Azetukalner, a unique drug for depression and epilepsy. The distribution of the annual change in earnings per share confirms these expectations, with -5.10 becoming the new value for this metric. Market capitalization relies on insurance procurement for patients with neurological disorders, while asset value depends exclusively on clinical trial outcomes, ignoring macroeconomic factors.

Xenon Pharmaceuticals Inc. - XENE Earnings growth in current year (period 07/04/2022 - 11/17/2026)

Analytical breakdowns and data insights for company Xenon (XENE)

- market capitalization indicators:
Basic company analysis:XENE, Xenon Pharmaceuticals Inc
Manufactured product of xenon-pharma.com

This indicator measures the annual growth of earnings per share, smoothing out quarterly volatility to assess the actual expansion of operational efficiency and the protection of capital from market noise. By analyzing the annual growth rate of net income per share, an investor can discern the financial stability of Xenon Pharmaceuticals (XENE), which, during clinical trials, depends critically on FDA approval for the commercialization of neuropharmacological developments.

Direct competitors

Earnings per share growth rate in current year Biogen Idec (BIIB)|NBIX (neurocrine.com) - Earnings growth in current year|Earnings per share growth rate in current year regencellbioscience.com RGC|Net earnings per share growth this year AXSM (Axsome Therapeutics, Inc.)|ACAD (ACADIA Pharma) - Earnings per share increase in current year|Viking Therapeutics, Inc. - Net earnings per share growth this year|Expected net earnings per share growth this year Supernus Pharmaceuticals (SUPN)|CPRX: Net earnings per share growth this year|Earnings per share increase in current year DNLI (Denali Therapeutics)|HRMY: Earnings growth in current year|BHVN (Biohaven Pharmaceutical) - Earnings per share growth in current year|Earnings per share growth in current year Amylyx|Earnings growth in current year Trevi Corp|Earnings growth in current year PRAX|AVXL (anavex.com) - Earnings per share increase in current year|CeriBell Inc - Net earnings per share growth this year|PRTA (Prothena Corporation plc) - Earnings per share trend in current year|ALEC - Earnings per share growth in current year|ANNX (Annexon Biosciences Inc.) - Earnings per share growth this year|OMER (omeros.com) - Net earnings per share growth this year|Earnings per share growth this year NGNE|Net earnings per share growth this year ACIU|Earnings growth in current year Voyager Pharma|Net earnings per share growth this year NMRA (Neumora Therapeutics, Inc.)|SCLX - Earnings per share growth rate in current year|Earnings per share growth in current year Tevogen Bio TVGN|Alpha Cognition Corp (ACOG) - Earnings per share growth rate in current year|CGTX: Net earnings per share growth this year|Inhibikase Therapeutics, Inc. - Net earnings per one share growth for the current year|SAVA: Earnings growth in current year|Earnings per share growth this year ASRT|COYA (coyatherapeutics.com) - Earnings growth in current year|Vistagen (VTGN) - Expected net earnings per share growth this year|Net earnings per share growth this year OVID (Ovid Rx)|Expected net earnings per share growth this year Acumen Pharmaceuticals, Inc.|Earnings growth in current year CRVO (CervoMed Corporation)|Net earnings per one share growth for the current year ATHE (Alterity Therapeutics Ltd)|Clene Nanomedicine - Earnings growth in current year|Net earnings per share change in current year pepgen.com (PEPG)|JUNS: Earnings growth in current year|Earnings per share growth this year RLMD|ANVS (Annovis Bio Inc) - Earnings growth in current year|Net earnings per share growth this year Grace Therapeutics, Inc. (GRCE)|Earnings growth in current year AIFF|Net earnings per one share growth for the current year KLTO|Earnings per share growth in current year neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings (RVPH) - Earnings per share growth rate in current year|MetaVia Inc. - Earnings growth in current year|Expected net earnings per share growth this year NeurAxis Inc NRXS|HSDT (Helius Medical Technologies Inc.) - Net earnings per share growth this year|Passage Bio Inc. (PASG) - Earnings growth in current year|Earnings per share growth in current year Neuphoria|Net earnings per share growth this year Minerva Neurosciences, Inc. (NERV)|Earnings per share growth in current year Athira (ATHA)|Addex Therapeutics - Earnings per share growth this year|Earnings per share growth in current year Alzamend Neuro, Inc. ALZN|Cyclerion (CYCN) - Earnings per share growth rate in current year|PTIX - Earnings per share growth in current year|Expected net earnings per share growth this year Pasithea Therapeutics Corp KTTA|Cortigent, Inc. (CRGT) - Earnings per share growth in current year|Avenue Therapeutics - Earnings per share increase in current year|BCLI (brainstorm-cell.com) - Earnings growth in current year|CARA: Earnings per share increase in current year|Earnings per share growth in current year Chromocell Therapeutics Corp (CHRO)|ELYM (Eliem Therapeutics Inc.) - Earnings per share increase in current year|Earnings growth in current year ITCI (Intra-Cellular Therapies Inc.)|Net earnings per share change in current year Longboard Pharma|MRNS - Earnings per share growth in current year|NKGen Biotech, Inc. (NKGN) - Net earnings per share growth this year|NRBO (NeuroBo Pharmaceuticals, Inc.) - Net earnings per share growth this year|Sage Therapeutics - Earnings per share increase in current year|Earnings per share growth in current year Synaptogenix, Inc.|TRVN: Earnings per share increase in current year|Earnings growth in current year VIGL|Net earnings per share growth this year Anew Medical, Inc. WENA|Earnings per share growth in current year Cerevel Therapeutics CERE